Invention Grant
- Patent Title: Sustained release pharmaceutical compositions comprising quetiapine in non-gellable polymers
- Patent Title (中): 包含不可凝胶聚合物中的喹硫平的缓释药物组合物
-
Application No.: US13002277Application Date: 2009-06-29
-
Publication No.: US08440223B2Publication Date: 2013-05-14
- Inventor: Avinash Krishnaji Velhal , Sunil Anantrao Mirajkar , Virendra Ramkrupal Kuril , Vineeth Raghavan , Ninad Deshpanday
- Applicant: Avinash Krishnaji Velhal , Sunil Anantrao Mirajkar , Virendra Ramkrupal Kuril , Vineeth Raghavan , Ninad Deshpanday
- Applicant Address: IN Mumbai, Maharashtra
- Assignee: Lupin Limited
- Current Assignee: Lupin Limited
- Current Assignee Address: IN Mumbai, Maharashtra
- Agency: Merchant & Gould P.C.
- Priority: IN1143/KOL/2008 20080701
- International Application: PCT/IN2009/000369 WO 20090629
- International Announcement: WO2010/001413 WO 20100107
- Main IPC: A61K9/14
- IPC: A61K9/14 ; A61K9/20 ; A61K9/48

Abstract:
A sustained release dosage form comprising Quetiapine or a pharmaceutically acceptable salt, polymorphs, solvates, hydrates thereof and one or more non-gellable release controlling polymer and one or more pharmaceutically acceptable excipient(s). A sustained release dosage form comprising first granulation comprising Quetiapine or its pharmaceutically acceptable salts, polymorphs, solvates, hydrates thereof and one or more release controlling material; and second granulation comprising one or more release controlling material which is the same or different than the one or more release controlling material of the first granulation and optionally quetiapine or its pharmaceutically acceptable salts, polymorphs, solvates, hydrates thereof. A method of preparing the sustained release dosage form by first and second granulation followed by milling; blending the said milled granules after second granulation with lubricant followed by compression to form a sustained release dosage form. A sustained release dosage form comprising immediate release core comprising Quetiapine or a pharmaceutically acceptable salt, polymorphs, solvates, hydrates thereof and one or more pharmaceutically acceptable excipients; and sustained release coating comprising one or more non-gellable release controlling material.
Public/Granted literature
- US20110151002A1 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING QUETIAPINE Public/Granted day:2011-06-23
Information query